정책/기획 보고서

개요
생명공학분야에 대한 새로운 비전과 대응전략의 제시는 비단 우리나라만의 현상이 아니며, 세계의 석학들과
주요 연구기관들은 2020년이 되면 전 세계적으로 바이오경제 시대가 도래될 것으로 예측하고 있습니다.
이러한 배경을 기초로 생명공학정책연구센터에서는『주요국의 생명공학 정책동향』의 발간을 통해 미국, 유럽, 일본, 중국의 정책동향에 대한 최신자료를 취합‧갱신하였습니다. 또한, 이들 주요국외에 Bio 2007 컨퍼런스
(미국 보스턴, 2007년 5월)에참가한 국가들의 정책동향에 대해서도 부록으로 정리하였습니다.
주요국의 생명공학분야에 대한 구체적인 정책동향은 의미있는 벤치마킹 자료로써 국가의 정책입안자에게는
국가정책수립의 효율성을 제고시켜 줄 것입니다.
목차
Ⅰ. 미국의 생명공학 정책동향
1. 서론 ·······································································································································3
2. NIH 중심의 생명공학 연구 ·······························································································7
3. 미국의 생명공학 분야 예산현황 ·······················································································9
4. 미국의 생명공학 주요 분야 투자 현황(NIH 중심) ····················································12
5. 기타 주요정책 ···················································································································16
6. 미국의 바이오산업 현황 ···································································································18
7. 시사점 ···································································································································20
8. 미국의 BT관련 사이트 ·····································································································21
Ⅱ. 유럽의 생명공학 정책동향
1. 유럽 경제의 위기 극복을 위한 신 리스본 전략 수립 ···············································25
2. FP 7 통한 지식유럽 건설로 경제성장 추구 ································································27
3. 영국의 주요 정책 동향 ·····································································································34
4. 독일의 주요 정책 동향 ·····································································································45
5. 프랑스의 주요 정책 동향 ·································································································56
Ⅲ. 일본의 생명공학 정책동향
1. 바이오 관련시책의 추진경위 ···························································································67
2. 일본의 바이오관련 시책으로서의 BT 전략대강 ·························································68
3. 2007년 Life-Science 분야 기본계획 개요 ····································································71
4. 주요기술동향 및 부처별 연구과제 ·················································································82
5. 시장동향 ·······························································································································87
6. 일본의 BT관련 사이트 ·····································································································91
Ⅳ. 중국의 생명공학 정책동향
1. 개요 ·······································································································································95
2. 중국의 생명공학 육성정책 현황 ·····················································································97
3. 중국의 생명공학기술 및 산업화 ···················································································100
4. 중국의 생명공학 투자현황 ·····························································································103
5. 중국 BT산업의 현황 ·······································································································104
6. 시사점 ·································································································································108
Ⅴ. 기타 주요국의 생명공학 정책동향
1. 이탈리아 ·····························································································································111
2. 스위스 ·································································································································114
3. 스웨덴 ·································································································································117
4. 노르웨이 ·····························································································································121
5. 핀란드 ·································································································································125
6. 아일랜드 ·····························································································································127
7. 스코틀랜드 ·························································································································129
8. 스페인 ·································································································································132
9. 이스라엘 ·····························································································································134
10. 푸에르토리코 ·····················································································································136
11. 인도 ·····································································································································138
12. 대만 ·····································································································································142
13. 말레이시아 ·························································································································145
14. 태국 ·····································································································································147
15. 싱가포르 ·····························································································································150
지식
동향
- 제도동향 유럽연합 SCCS, '화장품 내 나노물질 안전성 평가에 대한 지침' 발간 2024-11-22
- 기술동향 DNA 기반 데이터 저장·계산 기술 개발 2024-10-23
- 정책동향 [2024년 14호] (정책동향) 미국 12개 지역 기술 허브에 투자 2024-08-23
- 정책동향 GT글로벌산업정책동향_전략적 연구혁신 의제(SRIA): 그린디지털 전환을 위한 지속가능한 공급 및 원자재 사용에 대한 EU 파트너십 2024-08-01
- 정책동향 [2024년 7호] (정책동향) 한국, EU ‘호라이즌 유럽’ 프로그램 합류 협상 타결 (歐 EC, 3.25) 2024-05-22